The mechanisms of action of cyclosporin A : implications for its side effects.
Tonen K. K., Corporate Research & Development Laboratory.
N
N
Takahashi
D000591:Amino Acid Isomerases / Q000378:metabolism; D000818:Animals; D019703:Calcineurin; D002148:Calmodulin-Binding Proteins / Q000037:antagonists & inhibitors; D002352:Carrier Proteins / Q000378:metabolism; D016572:Cyclosporine / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology*; D019696:Peptidylprolyl Isomerase; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors
D002148:Calmodulin-Binding Proteins; D002352:Carrier Proteins; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019703:Calcineurin; D010749:Phosphoprotein Phosphatases; D000591:Amino Acid Isomerases; D019696:Peptidylprolyl Isomerase